Mirrabooka Investments Limited (MIR) ORDINARY FULLY PAID |
Financials |
$625 |
Update - Dividend/Distribution - MIR
|
31 Jan 2025 8:37AM |
$3.360 |
$3.210 |
fallen by
4.46%
|
|
Insurance Australia Group Limited (IAG) ORDINARY FULLY PAID |
Financials |
$20,720 |
Business Interruption update
|
31 Jan 2025 8:36AM |
$8.930 |
$8.760 |
fallen by
1.90%
|
|
Elixir Energy Limited (EXR) ORDINARY FULLY PAID |
Energy |
$41 |
Quarterly Activities Report and Appendix 5B Dec 2024
|
31 Jan 2025 8:35AM |
$0.045 |
$0.029 |
fallen by
35.56%
|
|
EXR - Price-sensitive ASX Announcement
Full Release
Key Points
- Operations at the Daydream-2 appraisal well were concluded.
- The Lorelle Sandstone flowed at stabilized rates of between 2.1 and 2.5 MMSCFD.
- A MOU was executed with AGIG for new gas infrastructure in the Taroom Trough.
- An increase in prospective resources of 712 Bcf was booked for ATP 2077.
- Elixir pursued farmout negotiations for the Grandis Project and Diona sub-block.
- Elixir has 100% interest in the Nomgon IX Coal Bed Methane PSC in Mongolia.
- Cash reserves as at December 31, 2024, were $2.7 million.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Telix Pharmaceuticals Limited (TLX) ORDINARY FULLY PAID |
Health Care |
$8,646 |
Application for quotation of securities - TLX
|
31 Jan 2025 8:35AM |
$28.810 |
$25.560 |
fallen by
11.28%
|
|
Live Verdure Ltd (LV1) ORDINARY FULLY PAID |
Consumer Staple |
$144 |
LV1 December 2024 Quarterly Business Review & Appendix 4C
|
31 Jan 2025 8:35AM |
$0.900 |
$0.915 |
risen by
1.67%
|
|
LV1 - Price-sensitive ASX Announcement
Full Release
Key Points
- LV1 acquired a controlling interest in Decidr.ai through a $13.2 million interest-free loan.
- Decidr.ai secured multi-year subscriptions with customers in healthcare, FMCG, finance, energy, and media.
- Strategic partnerships were established with The Growth Faculty, CareerOne, and ELMO Software.
- Edible Beauty's e-commerce sales grew 64% year-on-year and 143% quarter-on-quarter.
- David Brudenell transitioned to Executive Chairman to focus on group growth.
- The company reported a closing cash position of $4.62 million.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Little Green Pharma Ltd (LGP) ORDINARY FULLY PAID |
Health Care |
$33 |
Quarterly Activities Report and Appendix 4C
|
31 Jan 2025 8:33AM |
$0.110 |
$0.110 |
fallen by
0%
|
|
LGP - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue of $9.5 million, up 75% on prior corresponding period.
- Cash receipts of $10 million, up 90% on prior corresponding period.
- FY25Q3 year-to-date revenue of $27 million, surpassing prior full year revenue of $25.6 million.
- Strong German and UK market growth with $1 million in German flower sales in December.
- Launched new Lush Labs craft flower brand and multiple new oil products.
- Clinical trial treatment phase completed with positive feedback.
- Health House due diligence acquisition completed, negotiating SPA.
- Cash in bank of $3.7 million.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Mayfield Childcare Limited (MFD) ORDINARY FULLY PAID |
Consumer Discretionary |
$26 |
Letter from the Chair
|
31 Jan 2025 8:33AM |
$0.430 |
$0.350 |
fallen by
18.60%
|
|
Dubber Corporation Limited (DUB) ORDINARY FULLY PAID |
Information Technology |
$45 |
Proposed issue of securities - DUB
|
31 Jan 2025 8:33AM |
$0.054 |
$0.017 |
fallen by
68.52%
|
|
Clime Capital Limited (CAM) ORDINARY FULLY PAID |
Financials |
$106 |
Application for quotation of securities - CAM
|
31 Jan 2025 8:33AM |
$0.775 |
$0.710 |
fallen by
8.39%
|
|
Adherium Limited (ADR) ORDINARY FULLY PAID |
Health Care |
$5 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
31 Jan 2025 8:33AM |
$0.015 |
$0.007 |
fallen by
53.33%
|
|
ADR - Price-sensitive ASX Announcement
Full Release
Key Points
- Nearly 3,000 patients using Hailie® with pathway to reach 9,000 patients by calendar end 2025
- Customer receipts increased to $148,000, reflecting growing adoption and market traction
- AMC Health purchased 560 devices in December and placed a third order of 170 devices in January
- Potential entry into a new revenue segment: Pharmacy Benefit Management (PBM)
- Secured $674,000 R&D loan to support continued innovation
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Australian Dairy Nutritionals Group (AHF) ORDINARY FULLY PAID |
Consumer Staple |
$31 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
31 Jan 2025 8:32AM |
$0.065 |
$0.042 |
fallen by
35.38%
|
|
AHF - Price-sensitive ASX Announcement
Full Release
Key Points
- AHF reported net cash outflows from operations of $641,000 for Q2 FY25.
- Cash holdings at the end of Q2 FY25 were $4.48 million.
- The first production run for Nutura Organic has been completed successfully.
- The Future brand is set to be launched in China, with positive market feedback.
- Directors received $79,000 in remuneration during the December quarter.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Tabcorp Holdings Limited (TAH) ORDINARY FULLY PAID |
Consumer Discretionary |
$1,600 |
Formal appointment of Gillon McLachlan as MD & CEO
|
31 Jan 2025 8:31AM |
$0.665 |
$0.700 |
risen by
5.26%
|
|
Lycaon Resources Limited (LYN) ORDINARY FULLY PAID |
Materials |
$8 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
31 Jan 2025 8:31AM |
$0.145 |
$0.130 |
fallen by
10.34%
|
|
LYN - Price-sensitive ASX Announcement
Full Release
Key Points
- Maiden drill program completed at Stansmore Niobium-Rare Earth Elements target.
- Best assay result of 1m @ 425ppm Nb+Nd+Pr and 217ppm Y+Yb received.
- EIS exploration incentive grant of up to $180,000 for drilling costs.
- Ongoing assessment of additional geophysical targets in the West Arunta Project.
- Changes in board and management, with Tony Rovira joining the Board.
- Directors committed to invest $450,000 into the Company.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Telix Pharmaceuticals Limited (TLX) ORDINARY FULLY PAID |
Health Care |
$8,646 |
Telix Completes Acquisition of Tx Assets, Biologics Platform
|
31 Jan 2025 8:31AM |
$28.810 |
$25.560 |
fallen by
11.28%
|
|
TLX - Price-sensitive ASX Announcement
Full Release
Key Points
- Telix Pharmaceuticals Limited has acquired therapeutic assets from ImaginAb, Inc.
- The acquisition includes next-generation drug candidates and an innovative biologics technology platform.
- This deal enhances Telix's capabilities in precision medicine and therapeutic development.
- The transaction is valued at $45 million.
- A new research facility in Los Angeles will be part of Telix's operations.
- The acquisition includes a team of experts in protein engineering and radiopharmaceutical development.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Loyal Lithium Limited (LLI) ORDINARY FULLY PAID |
Materials |
- |
Quarterly Activities/Appendix 5B Cash Flow Report
|
31 Jan 2025 8:31AM |
$0.098 |
$0.130 |
risen by
32.65%
|
|
LLI - Price-sensitive ASX Announcement
Full Release
Key Points
- Loyal Lithium executed a definitive agreement to consolidate the Hidden Lake Lithium Project.
- Blair Way joined the Loyal Lithium Board, bringing industry expertise.
- The company has over $5.5 million in funding to advance its lithium assets.
- Exploration results at the Trieste Lithium Project expanded its prospectivity.
- Significant discoveries of new lithium pegmatite dykes were made during the quarter.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Dubber Corporation Limited (DUB) ORDINARY FULLY PAID |
Information Technology |
$45 |
Proposed issue of securities - DUB
|
31 Jan 2025 8:30AM |
$0.054 |
$0.017 |
fallen by
68.52%
|
|
PRO-PAC Packaging Limited (PPG) ORDINARY FULLY PAID |
Materials |
$3 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
31 Jan 2025 8:29AM |
$0.023 |
$0.017 |
fallen by
26.09%
|
|
PPG - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue of $73.1 million for the quarter.
- Increase of $4.3 million compared to the previous quarter.
- Drew down a $5.0 million asset finance facility.
- Entered a $13.0 million short-term financing facility with Bennamon Pty Ltd.
- Cash on hand was $0.6 million.
- Cash flows from operating activities showed an outflow of $6.0 million.
- No material changes to principal activities during the quarter.
- Appointment of new CEO Ian Shannon on 21 November 2024.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Pointsbet Holdings Limited (PBH) ORDINARY FULLY PAID |
Consumer Discretionary |
$396 |
Q2 FY25 Appendix 4C and Presentation
|
31 Jan 2025 8:28AM |
$0.980 |
$1.195 |
risen by
21.94%
|
|
PBH - Price-sensitive ASX Announcement
Full Release
Key Points
- Total revenue of A$124.4 million, up 6% year-on-year.
- EBITDA improved to A($3.3 million), a 75% increase from last year.
- 292.6k Cash Active Clients achieved, an all-time high.
- Challenges faced from customer-friendly results in Canada affecting net wins.
- Positive outlook for H2 FY25 with expectations of stronger cash flows.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
G11 Resources Limited (G11) ORDINARY FULLY PAID |
Materials |
$14 |
G11 December 2024 Quarterly Activities Report & Appendix 5B
|
31 Jan 2025 8:28AM |
$0.015 |
$0.015 |
fallen by
0%
|
|
G11 - Price-sensitive ASX Announcement
Full Release
Key Points
- Significant copper-rich massive sulphide intersections at Peveril-Grasmere.
- Drilling results confirmed VMS mineralisation extends over 1km of strike and 500m depth.
- G11 Resources focuses on the Koonenberry Project and potential acquisitions.
- The company's cash reserves decreased due to exploration and evaluation expenses.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Mach7 Technologies Limited (M7T) ORDINARY FULLY PAID |
Health Care |
$84 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
31 Jan 2025 8:28AM |
$0.370 |
$0.350 |
fallen by
5.41%
|
|
M7T - Price-sensitive ASX Announcement
Full Release
Key Points
- CARR of A$31.8M at 31 Dec 2024, up 15.6% on 30 Sep 2024.
- ARR Run Rate of A$25.1M, up 14.1% on 30 Sep 2024.
- Sales orders of A$14.0M in Q2 FY25.
- Cash of A$23.6M at 31 Dec 2024.
- On-market share buy-back of up to A$5M expected to commence on 3 Mar 2025.
- Reaffirmed FY25 guidance for 15-25% growth in CARR and revenue.
- Focus on customer intimacy and successful 'land and expand' model.
- Mach7 showcased products at RSNA, leading to a 78% increase in net new leads.
- No debt and disciplined cost management.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Dubber Corporation Limited (DUB) ORDINARY FULLY PAID |
Information Technology |
$45 |
Initial Director's Interest Notice - EP
|
31 Jan 2025 8:27AM |
$0.054 |
$0.017 |
fallen by
68.52%
|
|
Norwood Systems Limited (NOR) ORDINARY FULLY PAID |
Information Technology |
$9 |
Norwood varies cash drawdown facility
|
31 Jan 2025 8:27AM |
$0.028 |
$0.017 |
fallen by
39.29%
|
|
NOR - Price-sensitive ASX Announcement
Full Release
Key Points
- Norwood Systems Ltd has entered into a fifth deed of variation to a loan agreement.
- The cash drawdown facility has increased to $720,114.21.
- The repayment date has been extended to 14 February 2025.
- The loan amount has seen progressive increases from $300,000 to $640,000 in previous variations.
- The Board assesses the transaction as being arm's length and favorable for the company.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Immutep Limited (IMM) ORDINARY FULLY PAID |
Health Care |
$394 |
Immutep Quarterly Activities Report and Appendix 4C
|
31 Jan 2025 8:27AM |
$0.350 |
$0.270 |
fallen by
22.86%
|
|
IMM - Price-sensitive ASX Announcement
Full Release
Key Points
- Immutep's TACTI-004 trial received first regulatory approval.
- INSIGHT-003 trial demonstrated a median overall survival of 32.9 months.
- Promising results reported for head and neck cancer patients.
- Phase II trial in soft tissue sarcoma showed increased tumor hyalinization.
- Favorable safety results from Phase I of IMP761 trial.
- Publication on LAG-3 binding to MHC II published in Science Immunology.
- Strong cash position of A$159.26 million expected to last until end of CY2026.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Pointsbet Holdings Limited (PBH) ORDINARY FULLY PAID |
Consumer Discretionary |
$396 |
Details of Q2 FY25 Conference Call
|
31 Jan 2025 8:27AM |
$0.980 |
$1.195 |
risen by
21.94%
|
|
Dubber Corporation Limited (DUB) ORDINARY FULLY PAID |
Information Technology |
$45 |
Chair Appointment and Dir & Snr Mgt Subscription Commitment
|
31 Jan 2025 8:27AM |
$0.054 |
$0.017 |
fallen by
68.52%
|
|